Edition:
United States

DBV Technologies SA (DBV.PA)

DBV.PA on Paris Stock Exchange

25.10EUR
7 Dec 2018
Change (% chg)

€0.42 (+1.70%)
Prev Close
€24.68
Open
€24.84
Day's High
€25.62
Day's Low
€24.84
Volume
58,467
Avg. Vol
91,468
52-wk High
€47.38
52-wk Low
€24.52

Chart for

About

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to... (more)

Overall

Beta: 0.44
Market Cap(Mil.): €1,956.98
Shares Outstanding(Mil.): 24.10
Dividend: --
Yield (%): --

Financials

  DBV.PA Industry Sector
P/E (TTM): -- 31.13 33.63
EPS (TTM): -5.32 -- --
ROI: -54.08 15.55 15.02
ROE: -57.09 16.92 16.60

Earnings vs. Estimates